Forest Laboratories, Inc. to Present Aclidinium Bromide and Roflumilast Clinical Data at the International Conference

Posted: May 17th, 2013  |  Company/topic: Forest Laboratories
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Forest Laboratories, Inc (NYSE: FRX) today announced that they will present data related to aclidinium bromid…
Tags: , ,

Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting

Posted: May 16th, 2013  |  Company/topic: Forest Laboratories
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. (NYSE: FRX), today announced it will be presenting data…
Tags: , ,

Ironwood Pharmaceuticals and Forest Laboratories, Inc. to Present Linaclotide Data at

Posted: May 14th, 2013  |  Company/topic: Forest Laboratories
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) announced today they…
Tags: , ,

Forest Laboratories, Inc. Bets Up to $460 Million on Trevena, Inc. Heart Failure Drug

Posted: May 9th, 2013  |  Company/topic: Forest Laboratories
Website: BioSpace.com Featured News
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!KING OF PRUSSIA, Pa. and NEW YORK, May 9, 2013 /PRNewswire/ -- Trevena, Inc., (Trevena) a clinical stage phar…
Tags: , ,